The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Serious Infections Caused by Methicillin‐Resistant Staphylococcus aureus
Open accessAbstract
Although first identified just 14 decades ago, methicillin-resistant Staphylococcus aureus (MRSA) has undergone rapid evolutionary changes and epidemiologic expansion to become a major cause of nosocomial and community-acquired infections worldwide. Increasing resistance to vancomycin among MRSA strains in conjunction with availability of new antibiotics, including daptomycin and linezolid, have increased treatment choices but made clinical treatment decisions more challenging. This article describes the clinical features and management issues of 2 challenging-to-treat manifestations of MRSA infection, bacteremia and/or endocarditis and osteomyelitis. It also presents a brief review of community-associated MRSA infections and preventive strategies directed against MRSA. Micrococcus, which, when limited in extent and activity, causes acute suppurative inflammation (phlegmon), produces, when more extensive and intense in its action on the human system, the most virulent forms of septicaemia and pyaemia, as well as many forms intermediate between the two extremes. Alexander Ogston, on the organism now known as S. aureus [1]
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Self-citationGuidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
Ledell, K., Muto, C. A., Jarvis, W. R., & Farr, B. M. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502924 · Cited by 1,192
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
Chambers, H. F. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.4.781 · Cited by 1,127
Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042683 · Cited by 1,053
Self-citationPathogenesis of Methicillin‐Resistant Staphylococcus aureus Infection
Gordon, R. J., & Lowy, F. D. (2008) · Clinical Infectious Diseases · doi:10.1086/533591 · Cited by 961
Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A., & Wong-Beringer, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2138 · Cited by 860
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance
Hiramatsu, K. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00091-3 · Cited by 759
Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia
Fowler, V. G., Olsen, M. K., Corey, G. R., Woods, C. W., Cabell, C. H., Reller, L. B., Cheng, A. C., Dudley, T., & Oddone, E. Z. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.17.2066 · Cited by 652
The application of biofilm science to the study and control of chronic bacterial infections
Costerton, W. J., Veeh, R., Shirtliff, M. E., Pasmore, M. E., Post, C., & Ehrlich, G. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20365 · Cited by 649
Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C., John, J. F., Korvick, J. A., Kauffman, C. A., & Yu, V. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90063-u · Cited by 641
The application of biofilm science to the study and control of chronic bacterial infections
Costerton, W., Veeh, R., Shirtliff, M., Pasmore, M., Post, C., & Ehrlich, G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320365 · Cited by 630
Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375057 · Cited by 604
Active Bacterial Core Surveillance of the Emerging Infections Program Network
Schuchat, A., Hilger, T., Zell, E., Farley, M. M., Reingold, A., Harrison, L., Lefkowitz, L., Danila, R., Stefonek, K., Barrett, N., et al. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010114 · Cited by 592
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Wunderink, R. G., Rello, J., Cammarata, S., et al. (2003) · PubMed · Cited by 566
The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria
Swaney, S. M., Aoki, H., Ganoza, M. C., & Shinabarger, D. L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3251 · Cited by 555
Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact
Silverman, J. A., Mortin, L. I., VanPraagh, A. D. G., Li, T., & Alder, J. (2005) · The Journal of Infectious Diseases · doi:10.1086/430352 · Cited by 541
Chang, F.-Y., Peacock, J. E., Musher, D. M., Triplett, P., MacDonald, B. B., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091184.93122.09 · Cited by 530
Stevens, D. L., Herr, D., Lampiris, H., Hunt, J. L., Batts, D. H., Hafkin, B., & the Linezolid MRSA Study Group (2002) · Clinical Infectious Diseases · doi:10.1086/340353 · Cited by 506
Frazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.10.011 · Cited by 494
Staphylococcus aureus infections.
Tacconelli, E., Tumbarello, M., & Cauda, R. (1998) · PubMed · Cited by 470
Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey
Deresinski, S. (2005) · Clinical Infectious Diseases · doi:10.1086/427701 · Cited by 466
Blot, S. I., Vandewoude, K. H., Hoste, E. A., & Colardyn, F. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2229 · Cited by 463
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections
Weigelt, J., Itani, K., Stevens, D., Lau, W., Dryden, M., & Knirsch, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2260-2266.2005 · Cited by 457
Linezolid: The First Oxazolidinone Antimicrobial
Moellering, R. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-2-200301210-00015 · Cited by 455
Pallin, D. J., Egan, D. J., Pelletier, A. J., Espinola, J. A., Hooper, D. C., & Camargo, C. A. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.12.004 · Cited by 447
Fowler, V. G., Sanders, L. L., Sexton, D. J., Kong, L., Marr, K. A., Gopal, A. K., Gottlieb, G., McClelland, R. S., & Corey, G. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514686 · Cited by 441
Rubinstein, E., Cammarata, S. K., Oliphant, T. H., Wunderink, R. G., & the Linezolid Nosocomial Pneumonia Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/318486 · Cited by 440
Fowler, V. G., Li, J., Corey, G. R., Boley, J., Marr, K. A., Gopal, A. K., Kong, L. K., Gottlieb, G., Donovan, C. L., Sexton, D. J., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00250-7 · Cited by 423
Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals
Robicsek, A., Beaumont, J. L., Paule, S. M., Hacek, D. M., Thomson, R. B., Kaul, K. L., King, P., & Peterson, L. R. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00003 · Cited by 417
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399
Charles, P. G. P., Ward, P. B., Johnson, P. D. R., Howden, B. P., & Grayson, M. L. (2004) · Clinical Infectious Diseases · doi:10.1086/381093 · Cited by 384
Saiman, L., Keefe, M. O., Graham, P. L., Wu, F., Salim, B. S., Kreiswirth, B., LaSala, A., Schlievert, P. M., & Latta, P. D. (2003) · Clinical Infectious Diseases · doi:10.1086/379022 · Cited by 372
Carpenter, C. F., & Chambers, H. F. (2004) · Clinical Infectious Diseases · doi:10.1086/383472 · Cited by 358
Stryjewski, M. E., Szczech, L. A., Benjamin, D. K., Inrig, J. K., Kanafani, Z. A., Engemann, J. J., Chu, V. H., Joyce, M. J., Reller, L. B., Corey, G. R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510386 · Cited by 348
Markowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-390 · Cited by 343
Siberry, G. K., Tekle, T., Carroll, K., & Dick, J. (2003) · Clinical Infectious Diseases · doi:10.1086/377501 · Cited by 343
Vikram, H. R., Buenconsejo, J., Hasbun, R., & Quagliarello, V. J. (2003) · JAMA · doi:10.1001/jama.290.24.3207 · Cited by 335
Maree, C. L., Daum, R. S., Boyle-Vavra, S., Matayoshi, K., & Miller, L. G. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1302.060781 · Cited by 333
Self-citationLinezolid: The First Oxazolidinone Antimicrobial
Paterson, D. L., Pasculle, A. W., & McCurry, K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00017 · Cited by 328
Miller, L. G., & Diep, B. A. (2008) · Clinical Infectious Diseases · doi:10.1086/526773 · Cited by 318
Self-citationKollef, M. H., Rello, J., Cammarata, S. K., Croos-Dabrera, R. V., & Wunderink, R. G. (2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2088-1 · Cited by 315
Lipsky, B. A., Itani, K., Norden, C., & the Linezolid Diabetic Foot Infections Study Group (2004) · Clinical Infectious Diseases · doi:10.1086/380449 · Cited by 311
Risk of death from methicillin‐resistant Staphylococcus aureus bacteraemia: a meta‐analysis
Whitby, M., McLaws, M., & Berry, G. (2001) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2001.tb143562.x · Cited by 296
Simor, A. E., Phillips, E., McGeer, A., Konvalinka, A., Loeb, M., Devlin, H. R., & Kiss, A. (2007) · Clinical Infectious Diseases · doi:10.1086/510392 · Cited by 286
Staphylococcus aureus Sepsis and the Waterhouse–Friderichsen Syndrome in Children
Adem, P. V., Montgomery, C. P., Husain, A. N., Koogler, T. K., Arangelovich, V., Humilier, M., Boyle-Vavra, S., & Daum, R. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044194 · Cited by 279
Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children
FRANK, A. L., MARCINAK, J. F., MANGAT, P. D., TJHIO, J. T., KELKAR, S., SCHRECKENBERGER, P. C., & QUINN, J. P. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200206000-00010 · Cited by 271
Miller, L. G., Remington, F. P., Bayer, A. S., Diep, B., Tan, N., Bharadwa, K., Tsui, J., Perlroth, J., Shay, A., Tagudar, G., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511033 · Cited by 246
Self-citationCommunity‐Associated Methicillin‐Resistant Staphylococcus aureus
Weber, J. T. (2005) · Clinical Infectious Diseases · doi:10.1086/430788 · Cited by 244
Stevens, D. L., Smith, L. G., Bruss, J. B., McConnell-Martin, M. A., Duvall, S. E., Todd, W. M., & Hafkin, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3408-3413.2000 · Cited by 242
Mongkolrattanothai, K., Boyle, S., Kahana, M. D., & Daum, R. S. (2003) · Clinical Infectious Diseases · doi:10.1086/378277 · Cited by 230
Gorwitz, R. J., Jernigan, D. B., Powers, J. H., & Jernigan, J. A. (2006) · Cited by 226
Raad, I. I., & Sabbagh, M. F. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.75 · Cited by 224
Wilcox, M. H., Tack, K. J., Bouza, E., Herr, D. L., Ruf, B. R., Ijzerman, M. M., Croos‐Dabrera, R. V., Kunkel, M. J., & Knirsch, C. (2009) · Clinical Infectious Diseases · doi:10.1086/595686 · Cited by 223
Internalization ofStaphylococcus aureusby cultured osteoblasts
Hudson, M. C., Ramp, W. K., Nicholson, N. C., Williams, A. S., & Nousiainen, M. T. (1995) · Microbial Pathogenesis · doi:10.1006/mpat.1995.0075 · Cited by 215
Rajendran, P. M., Young, D., Maurer, T., Chambers, H., Perdreau-Remington, F., Ro, P., & Harris, H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00377-07 · Cited by 214 · cited 1×
“A recent randomized, double-blind trial compared standard of care antimicrobial treatment (cephalexin) after surgical incision and drainage of uncomplicated skin and softtissue abscesses [105].”
BackgroundCommunity Strain of Methicillin-Resistant Staphylococcus aureus Involved in a Hospital Outbreak
O’Brien, F. G., Pearman, J. W., Gracey, M., Riley, T. V., & Grubb, W. B. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.9.2858-2862.1999 · Cited by 213
Perlroth, J., Kuo, M., Tan, J., Bayer, A. S., & Miller, L. G. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.805 · Cited by 212
Self-citationWyllie, D. H., Crook, D. W., & Peto, T. E. A. (2006) · BMJ · doi:10.1136/bmj.38834.421713.2f · Cited by 210
Fifteen-Year Study of the Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus
Crum, N. F., Lee, R. U., Thornton, S. A., Stine, O. C., Wallace, M. R., Barrozo, C., Keefer-Norris, A., Judd, S., & Russell, K. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.004 · Cited by 204
Safety and tolerability of linezolid
French, G. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg253 · Cited by 203
Fowler, Jr., Sanders, L. L., Kong, L. K., McClelland, R. S., Gottlieb, G. S., Li, J., Ryan, T., Sexton, D. J., Roussakis, G., Harrell, L. J., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515076 · Cited by 196
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children
KAPLAN, S. L., DEVILLE, J. G., YOGEV, R., MORFIN, M. R., WU, E., ADLER, S., EDGE-PADBURY, B., NABERHUIS-STEHOUWER, S., & BRUSS, J. B. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000078160.29072.42 · Cited by 191
Linezolid‐Associated Peripheral and Optic Neuropathy, Lactic Acidosis, and Serotonin Syndrome
Narita, M., Tsuji, B. T., & Yu, V. L. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.8.1189 · Cited by 190
Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization
Loeb, M. B., Main, C., Eady, A., & Walkers-Dilks, C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003340 · Cited by 189
Bites of Brown Recluse Spiders and Suspected Necrotic Arachnidism
Swanson, D. L., & Vetter, R. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041184 · Cited by 189
Rosen, A. B., Fowler, V. G., Corey, G. R., Downs, S. M., Biddle, A. K., Li, J., & Jollis, J. G. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00004 · Cited by 186
Treatment of Community-Associated Methicillin-Resistant Staphylococcus aureus Infections
Kaplan, S. L. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000164162.00163.9d · Cited by 175
The carrier state: methicillin-resistant Staphylococcus aureus
Casewell, M. W., & Hill, R. L. R. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.supplement_a.1 · Cited by 165
Gorwitz, R. J. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31815819bb · Cited by 164
Pertel, P. E., Bernardo, P., Fogarty, C., Matthews, P., Northland, R., Benvenuto, M., Thorne, G. M., Luperchio, S. A., Arbeit, R. D., & Alder, J. (2008) · Clinical Infectious Diseases · doi:10.1086/533441 · Cited by 162
Clinical Features of Staphylococcus aureus Endocarditis: A 10-Year Experience in Denmark
Røder, B. L., Wandall, D. A., Frimodt-Møller, N., Espersen, F., Skinhøj, P., & Rosdahl, V. T. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.462 · Cited by 162
Malanoski, G. J., Samore, M. H., Pefanis, A., & Karchmer, A. W. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.11.1161 · Cited by 161
Lautenschlager, S., Herzog, C., & Zimmerli, W. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.4.567 · Cited by 154
Staphylococcus aureus Prosthetic Valve Endocarditis: Optimal Management and Risk Factors for Death
John, M. D. V., Hibberd, P. L., Karchmer, A. W., Sleeper, L. A., & Calderwood, S. B. (1998) · Clinical Infectious Diseases · doi:10.1086/516378 · Cited by 153
Short-Course Therapy of Catheter-related Staphylococcus aureus Bacteremia
Jernigan, J. A., & Farr, B. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-4-199308150-00010 · Cited by 147
Miller, L. G., Quan, C., Shay, A. C., Mostafaie, K., Bharadwa, K., Tan, N., Matayoshi, K., Cronin, J., Tan, J. A., Tagudar, G., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511041 · Cited by 144
Self-citationJones, J., Rogers, T. J., Brookmeyer, P., Dunne, W. M., Storch, G. A., Coopersmith, C. M., Fraser, V. J., & Warren, D. K. (2007) · Clinical Infectious Diseases · doi:10.1086/520663 · Cited by 138
Sakoulas, G., Eliopoulos, G. M., Alder, J. D., & Eliopoulos, C. T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1714-1718.2003 · Cited by 133
Long-term Efficacy of Intranasal Mupirocin Ointment
Doebbeling, B. N. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130101013 · Cited by 126
New antimicrobial agents for the treatment of Gram-positive bacterial infections
Aksoy, D. Y., & Ünal, S. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01933.x · Cited by 115
Rehm, S. J., Boucher, H. W., Levine, D. P., Campion, M., Eisenstein, B. I., Vigliani, G. A., Corey, G. R., & Abrutyn, E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn372 · Cited by 114
Self-citationBernard, L., Elhajj, Pron, B., Lotthé, A., Gleizes, V., Signoret, F., Denormandie, P., Gaillard, J. L., Perronne, C., & l'Osteite, G. D. S. (2001) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2001.00380.x · Cited by 112
Loveday, H. P., Pellowe, C. M., Jones, S. R. L. J., & Pratt, R. J. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.01.002 · Cited by 111
Long‐Term Outcome of Infective Endocarditis: The Impact of Early Surgical Intervention
Bishara, J., Leibovici, L., Gartman‐Israel, D., Sagie, A., Казаков, А. Д., Miroshnik, E., Ashkenazi, S., & Pitlik, S. D. (2001) · Clinical Infectious Diseases · doi:10.1086/323785 · Cited by 107
Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis
Lamp, K. C., Friedrich, L. V., Mendez-Vigo, L., et al. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.07.010 · Cited by 106
Community-Associated Methicillin-Resistant Staphylococcus aureus
Gorwitz, R. J. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818a3450 · Cited by 103
Palavecino, E. L. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-468-1_1 · Cited by 90
Linezolid-Associated Peripheral Neuropathy
Rho, J. P., Sia, I. G., Crum, B. A., Dekutoski, M. B., & Trousdale, R. T. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.7.927 · Cited by 90
Drago, L., Vecchi, E. D., Nicola, L., & Gismondo, M. R. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-111 · Cited by 88
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Snydman, D. R. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70050-6 · Cited by 87
Ogston, A. (1882) · PubMed · Cited by 81
Snydman, D. R. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70362-6 · Cited by 78
Strausbaugh, L. J., Siegel, J. D., Weinstein, R. A., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500408 · Cited by 75
The Treatment Triangle for Staphylococcal Infections
Grayson, M. L. (2006) · New England Journal of Medicine · doi:10.1056/nejme068152 · Cited by 69
Linezolid therapy for infective endocarditis
Muñoz, P., Rodríguez-Creixéms, M., Moreno, M., Marín, M., Ramallo, V., Bouza, E., & GAME Study Group (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01585.x · Cited by 68
Lalani, T., Boucher, H. W., Cosgrove, S. E., Fowler, V. G., Kanafani, Z. A., Vigliani, G. A., Campion, M., Abrutyn, E., Levine, D. P., Price, C. S., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm437 · Cited by 67
Self-citationSullenberger, A. L., Avedissian, L. S., & Kent, S. M. (2005) · PubMed · Cited by 64
Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children
Wible, K. L., Tregnaghi, M., BRUSS, J. B., Fleishaker, D. L., NABERHUIS-STEHOUWER, S., & Hilty, M. D. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000059403.21440.2c · Cited by 63
Linezolid and Vancomycin for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
Powers, J. H., Ross, D. B., Lin, D., & Soreth, J. M. (2004) · CHEST Journal · doi:10.1378/chest.126.1.314 · Cited by 54
Vaudaux, P. E. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg277 · Cited by 48
Chronic osteomyelitis of the femur: value of PET imaging
Robiller, F., Stumpe, K. D. M., Kossmann, T., Weisshaupt, D., Bruder, E., & von Schulthess, G. K. (2000) · European Radiology · doi:10.1007/s003300051019 · Cited by 47
Linezolid induced toxic optic neuropathy
Kulkarni, K. N., & Priore, L. V. D. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.074237 · Cited by 40
Diekema, D. J., & Climo, M. W. (2008) · JAMA · doi:10.1001/jama.299.10.1190 · Cited by 39
Schmitz, A., Kälicke, T., Willkomm, P., Grünwald, F., Kandyba, J., & Schmitt, O. (2000) · Journal of Spinal Disorders · doi:10.1097/00002517-200012000-00016 · Cited by 37
Antibiotic Therapy of Methicillin-Resistant Staphylococcus Aureus in Critical Care
Tverdek, F. P., Crank, C. W., & Segreti, J. C. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2007.12.013 · Cited by 36
Bartlett, J. G. (2004) · Infectious Diseases in Clinical Practice · Cited by 26
Treatment of chronic experimentalStaphylococcus aureus osteomyelitis with LY146032 and vancomycin
Luu, Q., Buxton, T. B., Nelson, D. R., et al. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967482 · Cited by 23
Optimizing Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia
Cosgrove, S. E., & Fowler, V. G. (2007) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2007-996409 · Cited by 14
Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals
(2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00001 · Cited by 10
Pruett, T. L. (2009) · Yearbook of Surgery · doi:10.1016/s0090-3671(09)79472-8 · Cited by 9
Is antimicrobial therapy needed to manage uncomplicated skin and soft-tissue abscesses?
Ellis, M. W. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.1.9 · Cited by 3
Cited by
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Update on the antibiotic resistance crisis
Rossolini, G. M., Arena, F., Pecile, P., & Pollini, S. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.09.006 · Cited by 695
Antibiotic Resistance and the MRSA Problem
Vestergaard, M., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 490
Society's failure to protect a precious resource: antibiotics
Carlet, J., Collignon, P., Goldmann, D., Goossens, H., Gyssens, I. C., Harbarth, S., Jarlier, V., Levy, S. B., N'Doye, B., Pittet, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60401-7 · Cited by 322
Batko, I. Z., Flannagan, R. S., Guariglia-Oropeza, V., Sheldon, J. R., & Heinrichs, D. E. (2021) · Journal of Bacteriology · doi:10.1128/jb.00458-21 · Cited by 19
Metadata
- Authors
- Boucher, H., Miller, L. G., & Razonable, R. R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-09-15
- Volume
- 51
- Issue
- S2
- Pages
- S183-S197
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2144289529
- Cited by
- 252
- References
- 123
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.